MolNFT v1 · #171948 · protein
MREC
6ZLV · Rod shape-determining protein mrec: “MREC”. Electron microscopy, 9 pockets (best druggability 0.76). MolNFT v1 #171948 on GenesisL1: 3D structure, binding sites and pockets in GL1X.
- PDB
- 6ZLV
- Type
- protein
- Length
- 704 residues
- Chains
- 4
- Method
- electron microscopy
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Rod shape-determining protein mrec
- UniProt
- A0A6A9K3A1
- Pockets
- 9 · best druggability 0.76
Structure
electron microscopy · 1 distinct chain · 11% helix, 40% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A, B, C, D | Rod shape-determining protein mrec | protein | 176 | 11% helix, 40% strand | A0A6A9K3A1 |
Pockets
9 pockets found on a 1 Å grid, 5 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 699 | 0.76 | 0.81 | 110 | empty |
| 2 | 52 | 0.58 | 0.91 | 19 | empty |
| 3 | 93 | 0.56 | 0.86 | 25 | empty |
| 4 | 151 | 0.52 | 0.80 | 26 | empty |
| 5 | 136 | 0.51 | 0.80 | 23 | empty |
Interfaces
6 interfaces between chains.
- C–D · 894 Ų buried · 23 hydrogen bonds · protein-protein
- A–B · 893 Ų buried · 23 hydrogen bonds · protein-protein
- A–C · 761 Ų buried · 5 hydrogen bonds · protein-protein
- B–D · 752 Ų buried · 5 hydrogen bonds · protein-protein
- A–D · 135 Ų buried · 0 hydrogen bonds · protein-protein
Compared structures
- 6ZLV · MreC · the same entry in another collection · chain A against A, TM-score 1.00
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt A0A6A9K3A1
- Elsewhere: RCSB PDB 6ZLV · PDBe 6ZLV · UniProt A0A6A9K3A1
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.